A Combinatorial Approach to Wound Healing for Protein, Gene and Cell Therapeutics
A Combinatorial Approach to Wound Healing for Protein, Gene and Cell Therapeutics
批准号:
7670682
负责人:
ANDREW BAIRD
金额:
$9.72万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-08-01 至 2010-07-31
关键词:
Ambulatory CareAntibodiesBackBacteriophagesBecaplerminBindingBiological MarkersBiological ProductsBiological Response Modifier TherapyBiologyBone MarrowBurn TraumaCaringCell surfaceCellsChimera organismCicatrixClassCommunitiesComplexDirected Molecular EvolutionDisciplineDrug Delivery SystemsDrug KineticsEpidermal Growth FactorEquipment and supply inventoriesFibroblast Growth FactorGene DeliveryGene ProteinsGenesGrowth FactorGrowth Factor GeneHematopoieticHumanLeadLibrariesLigandsMalignant NeoplasmsMesenchymal Stem CellsMethodologyMethodsMiningModelingMolecular BiologyNucleic AcidsPatientsPeptide LibraryPeptidesPhage DisplayPharmaceutical PreparationsPlatelet-Derived Growth FactorPolymerase Chain ReactionPrincipal InvestigatorProteinsProto-Oncogene Proteins c-sisPublic HealthReagentReconstructive Surgical ProceduresRecoveryResearchScreening procedureStem cellsStromal CellsTechniquesTechnologyTestingTherapeuticTimeUnited States Food and Drug AdministrationWorkplaceWound HealingWounds and Injuriesanalogbasecombinatorialdesigndirected evolutionexperienceimprovedin vivoin vivo Modelinjury and repairinnovationmultidisciplinarynovelnovel therapeuticspre-clinicalprecursor cellpressureprogenitorresponseskillsstemstem cell therapytherapeutic genetherapeutic targetvectorwound
中文摘要
最初在一个研究领域(如癌症)开发的技术,有时引进缓慢
在其他领域(如伤口愈合)。本提案的总体目标是应用一种这样的先进技术,
体内组合生物学应用于伤口愈合(WH),从而产生和修饰潜在的WH生物治疗剂。
我们将用4种技术筛选新的治疗方法:(1)生物淘选,以确定靶向肽,
缺血性伤口更好的药物输送;(2)SNAAP筛选,以创造最佳的生长
因子嵌合体具有改善的伤口修复药代动力学;(3)LIVE恢复以进化基因
递送载体,针对WH环境进行遗传优化,以及(4)RBT以鉴定细胞表面生物标记
在骨髓来源的前体细胞上的签名,其可以迁移到伤口并植入伤口。
创新:组合技术从未应用于伤口愈合范例。因为
噬菌体展示技术可以回答其他技术无法回答的研究问题,它将为WH开辟新的途径,
research.它将增加对WH机制的基本理解,识别本质上有用的标记
签名并创建新的生物识别剂。
需要多学科团队:噬菌体展示作为“分子生物学试剂盒”和多学科技能失败
在核心和项目提供(1)具体的经验,以创建,优化和分析库(QA/QC,
库存),(2)获得原型伤口愈合模型,(3)设计,开发和测试理想的能力
原型屏幕和(4)命中导致伤口愈合社区的转变。
对伤口愈合的影响:组合技术可应用于几乎任何WH范例(例如,
创伤、烧伤)。它将产生独特的研究试剂,临床前候选药物,
改进的基因载体和更好地了解祖细胞,干细胞和基质细胞靶向WH。它
可以在各种不同的WH范例中有辅助应用。
与公共卫生的相关性:门诊护理的进展增加了加速正常WH的压力,
最大限度地减少重建手术,减少疤痕形成,让患者重返工作场所。
最初为其他学科开发的技术,产生了全新的方法来增强,修改
并了解WH反应的方式,可以影响各种不同类型的伤口。
英文摘要
Technologies originally developed in one field of research (e.g. cancer), is sometimes slow to be introduced
in other fields (e.g. wound healing). The overall objective of this proposal is to apply one such advance, in
vivo combinatorial biology, to wound healing (WH) so as to create and modify potential WH biotherapeutics.
We will screen for new therapeutics with 4 technologies: (1) Biopanning to identify targeting peptides for the
ischemic wound for better drug delivery; (2) SNAAP screening to create pharmacologically optimized growth
factor chimera with improved pharmacokinetics for wound repair; (3) LIVE recoveries to evolve a gene
delivery vector, genetically optimized for the WH milieu and (4) RBT to identify cell surface biomarking
signatures on bone marrow-derived precursor cells that can migrate to and engraft the wound.
Innovation: Combinatorial technologies have never been applied to a wound healing paradigm. Because
phage display can answer research questions like no other technique, it will open new venues of WH
research. It will increase basic understanding of WH mechanisms, identify intrinsically useful biomarking
signatures and create new biotherapeutic agents.
Need for a multidisciplinary team: Phage display fails as a "molecular biology kit" and multidisciplinary skills
in cores and projects provide (1) specific experience to create, optimize and analyze libraries (QA/QC,
inventory), (2) access to prototypic wound healing models, (3) the ability to design, develop and test ideal
prototypic screens and (4) the hit to lead transformation for the wound healing community.
Impact on wound healing: Combinatorial techniques could be applied to virtually any WH paradigm (e.g.
trauma, burns). It will generate unique research reagents, preclinical candidates, pharmacologically
improved gene vectors and a better understanding of progenitor, stem and stromal cell targeting to WH. It
can have ancillary applications in all kinds of different WH paradigms.
Relevance to public health: Progress in ambulatory care increases pressures to accelerate normal WH,
minimize reconstructive surgery, modify scar formation and return the patient to the workplace.
Technologies originally developed for other disciplines, generates completely new ways to enhance, modify
and understand the WH response in a fashion that can impacts all kinds of different kinds of wounds.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting the choroid plexus for drug translocation into CSF
-
批准号:7848683
-
项目类别:
-
资助金额:$2.38万
-
财政年份:2009
-
负责人:ANDREW BAIRD
-
依托单位:
A Combinatorial Approach to Wound Healing for Protein, Gene and Cell Therapeutics
-
批准号:7815960
-
项目类别:
-
资助金额:$42.02万
-
财政年份:2009
-
负责人:ANDREW BAIRD
-
依托单位:
Targeting the choroid plexus for drug translocation into CSF
-
批准号:7501899
-
项目类别:
-
资助金额:$15.46万
-
财政年份:2007
-
负责人:ANDREW BAIRD
-
依托单位:
Targeting the choroid plexus for drug translocation into CSF
-
批准号:7996282
-
项目类别:
-
资助金额:$15.94万
-
财政年份:2007
-
负责人:ANDREW BAIRD
-
依托单位:
Targeting the choroid plexus for drug translocation into CSF
-
批准号:7329851
-
项目类别:
-
资助金额:$26.83万
-
财政年份:2007
-
负责人:ANDREW BAIRD
-
依托单位:
A Combinatorial Approach to Wound Healing for Protein, Gene and Cell Therapeutics
-
批准号:7670320
-
项目类别:
-
资助金额:$68.9万
-
财政年份:2006
-
负责人:ANDREW BAIRD
-
依托单位:
A Combinatorial Approach to Wound Healing for Protein, Gene and Cell Therapeutics
-
批准号:7137798
-
项目类别:
-
资助金额:$94.4万
-
财政年份:2006
-
负责人:ANDREW BAIRD
-
依托单位:
A Combinatorial Approach to Wound Healing for Protein, Gene and Cell Therapeutics
-
批准号:7270626
-
项目类别:
-
资助金额:$20.24万
-
财政年份:2006
-
负责人:ANDREW BAIRD
-
依托单位:
A Combinatorial Approach to Wound Healing for Protein, Gene and Cell Therapeutics
-
批准号:7491591
-
项目类别:
-
资助金额:$59.25万
-
财政年份:2006
-
负责人:ANDREW BAIRD
-
依托单位:
A Combinatorial Approach to Wound Healing for Protein, Gene and Cell Therapeutics
-
批准号:7573778
-
项目类别:
-
资助金额:$48.2万
-
财政年份:2006
-
负责人:ANDREW BAIRD
-
依托单位:
Directed Delivery of Growth Factors to the CNS
-
批准号:6934761
-
项目类别:
-
资助金额:$29.02万
-
财政年份:2005
-
负责人:ANDREW BAIRD
-
依托单位:
CNS FIBROBLAST GROWTH FACTORS--ACTIVITY AND REGULATION
-
批准号:6598880
-
项目类别:
-
资助金额:$24.81万
-
财政年份:2002
-
负责人:ANDREW BAIRD
-
依托单位:
CNS FIBROBLAST GROWTH FACTORS--ACTIVITY AND REGULATION
-
批准号:6573091
-
项目类别:
-
资助金额:$24.81万
-
财政年份:2001
-
负责人:ANDREW BAIRD
-
依托单位:
CNS FIBROBLAST GROWTH FACTORS--ACTIVITY AND REGULATION
-
批准号:6469781
-
项目类别:
-
资助金额:$24.81万
-
财政年份:2001
-
负责人:ANDREW BAIRD
-
依托单位:
CNS FIBROBLAST GROWTH FACTORS--ACTIVITY AND REGULATION
-
批准号:6354780
-
项目类别:
-
资助金额:$24.81万
-
财政年份:2000
-
负责人:ANDREW BAIRD
-
依托单位:
CNS FIBROBLAST GROWTH FACTORS--ACTIVITY AND REGULATION
-
批准号:6345009
-
项目类别:
-
资助金额:$24.81万
-
财政年份:2000
-
负责人:ANDREW BAIRD
-
依托单位:
CNS FIBROBLAST GROWTH FACTORS--ACTIVITY AND REGULATION
-
批准号:6112343
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1998
-
负责人:ANDREW BAIRD
-
依托单位:
CNS FIBROBLAST GROWTH FACTORS--ACTIVITY AND REGULATION
-
批准号:6243674
-
项目类别:
-
资助金额:$14.17万
-
财政年份:1997
-
负责人:ANDREW BAIRD
-
依托单位:
SMALL INSTRUMENTATION GRANT
-
批准号:2149777
-
项目类别:
-
资助金额:$2.95万
-
财政年份:1994
-
负责人:ANDREW BAIRD
-
依托单位:
BRAIN PEPTIDES IN PITUITARY FUNCTIONS AND DIABETES
-
批准号:2137231
-
项目类别:
-
资助金额:$4.71万
-
财政年份:1989
-
负责人:ANDREW BAIRD
-
依托单位:
海外基金